{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:55:29Z","timestamp":1768733729345,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpainsymman.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:24:15Z","timestamp":1752593055000},"page":"e244-e249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improvement of Fatigue Due to Placebo in Blinded and Open Labeled Cancer Fatigue Treatment Trials"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9012-5549","authenticated-orcid":false,"given":"Reema","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levi Jo","family":"Manuntag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-9326","authenticated-orcid":false,"given":"Kristofer","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-0412","authenticated-orcid":false,"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Yennurajalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.jpainsymman.2025.07.005_bib0001","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1200\/JCO.2007.12.6672","article-title":"Health-related quality of life and symptom management research sponsored by the National Cancer Institute","volume":"25","author":"Minasian","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.07.005_bib0002","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","article-title":"Cancer-related fatigue, version 2.2015","volume":"13","author":"Berger","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.07.005_bib0003","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1023\/A:1008318932641","article-title":"Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum","volume":"11","author":"Stone","year":"2000","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.jpainsymman.2025.07.005_bib0004","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/djg014","article-title":"National Institutes of Health State-of-the-science Conference Statement: symptom management in Cancer: pain, depression, and fatigue, July 15-17, 2002","volume":"95","author":"Patrick","year":"2003","journal-title":"J Nat Cancer Institute"},{"issue":"20","key":"10.1016\/j.jpainsymman.2025.07.005_bib0005","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.24.00541","article-title":"Management of fatigue in adult survivors of cancer: ASCO\u2013Society for Integrative Oncology Guideline update","volume":"42","author":"Bower","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2025.07.005_bib0006","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fpsyt.2019.00470","article-title":"Placebo and nocebo effects across symptoms: from pain to fatigue, dyspnea, nausea, and itch","volume":"10","author":"Wolters","year":"2019","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.005_bib0007","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/cncr.24751","article-title":"Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer","volume":"116","author":"de la Cruz","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jpainsymman.2025.07.005_bib0008","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmjspcare-2019-002163","article-title":"Placebo response in trials of drug treatments for cancer-related fatigue: a systematic review, meta-analysis and meta-regression","volume":"10","author":"Roji","year":"2020","journal-title":"BMJ Support Palliat Care"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.005_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jebm.12251","article-title":"Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis","volume":"10","author":"Charlesworth","year":"2017","journal-title":"J Evid Based Med"},{"issue":"25","key":"10.1016\/j.jpainsymman.2025.07.005_bib0010","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","article-title":"Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer","volume":"31","author":"Yennurajalingam","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7\u20138","key":"10.1016\/j.jpainsymman.2025.07.005_bib0011","first-page":"751","article-title":"Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study","volume":"69","author":"Bruera","year":"1985","journal-title":"Cancer Treat Rep"},{"issue":"23","key":"10.1016\/j.jpainsymman.2025.07.005_bib0012","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2007.10.9231","article-title":"Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial","volume":"25","author":"Bruera","year":"2007","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.jpainsymman.2025.07.005_bib0013","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.2005.02.8506","article-title":"Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial","volume":"24","author":"Bruera","year":"2006","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jpainsymman.2025.07.005_bib0014","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1200\/JCO.2012.45.3696","article-title":"Methylphenidate and\/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial","volume":"31","author":"Bruera","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jpainsymman.2025.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.6004\/jnccn.2017.0149","article-title":"A double-blind, randomized, placebo-controlled trial of Panax Ginseng for cancer-related fatigue in patients with advanced cancer","volume":"15","author":"Yennurajalingam","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.jpainsymman.2025.07.005_bib0016","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/oncolo\/oyac184","article-title":"Open-label placebo for the treatment of cancer-related fatigue in patients with advanced cancer: a randomized controlled trial","volume":"27","author":"Yennurajalingam","year":"2022","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.005_bib0017","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2025.07.005_bib0018","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.005_bib0019","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0959-8049(02)00628-7","article-title":"Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa","volume":"39","author":"Patrick","year":"2003","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.005_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","article-title":"The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients","volume":"7","author":"Bruera","year":"1991","journal-title":"J Palliat Care"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.005_bib0021","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2008.03.008","article-title":"The Association of Physical and Psychological Symptom burden with time to death among palliative cancer outpatients","volume":"37","author":"Cheung","year":"2009","journal-title":"J Pain Sympt Manage"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.005_bib0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","article-title":"The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients","volume":"7","author":"Bruera","year":"1991","journal-title":"J Palliat Care"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.005_bib0023","first-page":"55","article-title":"A review of the reliability and validity of the Edmonton Symptom Assessment System","volume":"16","author":"Richardson","year":"2009","journal-title":"Curr Oncol (Toronto, Ont)"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.005_bib0024","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1038\/s41598-021-83148-6","article-title":"Effects of open-label placebos in clinical trials: a systematic review and meta-analysis","volume":"11","author":"von Wernsdorff","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.005_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010091","article-title":"Meta-analysis of pharmacological, nutraceutical and phytopharmaceutical interventions for the treatment of cancer related fatigue","volume":"15","author":"Yennurajalingam","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.jpainsymman.2025.07.005_bib0026","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJMra1907805","article-title":"Placebo and nocebo effects","volume":"382","author":"Colloca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2025.07.005_bib0027","doi-asserted-by":"crossref","unstructured":"Colloca L, Noel J, Franklin P, Seneviratne C Placebo effects through the lens of translational research. 2023;doi:10.1093\/med\/9780197645444.001.0001","DOI":"10.1093\/med\/9780197645444.001.0001"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.005_bib0028","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cncr.31790","article-title":"The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms","volume":"125","author":"Bower","year":"2019","journal-title":"Cancer"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242500716X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242500716X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:09:15Z","timestamp":1756361355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539242500716X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S088539242500716X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.07.005","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of Fatigue Due to Placebo in Blinded and Open Labeled Cancer Fatigue Treatment Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}